Tuberculosis remains a major health problem in the world, which is compound
ed further by the alarmingly high rate of M. tuberculosis infections in AID
S patients, Thus, there is an urgent need to advance our understanding of t
he mycobacterium to develop new drugs. The extraordinary recent development
s in mycobacterial genetic research, particularly in genomics will greatly
facilitate this goat. The knowledge of the entire genome sequence of M. tub
erculosis will help in designing new chemotherapeutic and immunotherapeutic
interventions, This review highlights recent developments in genomics, myc
obacterial genetics, novel Vaccine strategies, and our understanding of tub
erculous dormancy. Curr Opin Infect Dis 12:415-424. (C) 1999 Lippincott Wil
liams & Wilkins.